ArticleFrontiers in neuroscience2026
Development and validation of a nomogram for early prediction of post-stroke shoulder-hand syndrome: a retrospective cohort study.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Shoulder-hand syndrome (SHS) is a prevalent complication following strokes. At present, there is no established and dependable method for early prediction of SHS risk. Thus, we undertook this study to create and validate a nomogram for early prediction of SHS following ischemic stroke (IS), with the aim of informing the development of SHS-specific follow-up protocols in clinical practice. Methods: We retrospectively collected data on IS patients admitted to the Affiliated Panyu Central Hospital of Guangzhou Medical University from October 1, 2019 to March 31, 2024. The data was randomly split into a training set and a validation set in a 7:3 ratio, and LASSO regression was used to filter the modeling variables. In addition, the consistency index, area under the receiver operating characteristic curve (AUC), and calibration curve were used to verify the accuracy and discriminant power of the nomogram. Results: A total of 514 patients were enrolled in our study. Significant predictors contained sex, occupation, residence, osteoarthritis, gouty arthritis, myodynamia, heart rate, neutrophils, blood glucose, aspartate aminotransferase, and activated partial thromboplastin time. The AUC for the model constructed on the basis of these predictors was 0.777 (95% CI: 0.727-0.826) in the training set and 0.698 (95% CI: 0.615-0.781) in the validation set. Conclusion: The nomogram constructed on the basis of common clinical features has a high performance in predicting the occurrence of SHS within 6 months after stroke. It can provide a reference for the development of specific prevention programs during clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.